Webcast Discusses Health Economics Analysis of SCID Newborn Screening in France

TREC Towards HealthPerkinElmer features a webcast with Dr. Isabelle Durand-Zaleski of the Paris Health Economics and Health Services Research Unit discussing the cost effectiveness of implementing systematic screening for Severe Combined Immune Deficiency (SCID). It explains the costs of screening all newborns and the cost potentially avoided by an early treatment (e.g. bone marrow transplant). Click here to watch the webcast.